Analyst says he’s thrown in the towel on Novo Nordisk after latest setback

Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to downgrade the stock for the first time in five years.

24 Feb, 12:51 — 24 Feb, 12:51

Post Share

ℹOnly 1 source covers this story

Read at source (1 outlet)

marketwatch19h ago

Novo Nordisk and Eli Lilly shares both fall after Ozempic price-cut plan

Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for popular weight-loss drugs.

By Steve Goldstein

Read full article →

PERSPECTA

PERSPECTA

Analyst says he’s thrown in the towel on Novo Nordisk after latest setback

Read at source (1 outlet)

Novo Nordisk and Eli Lilly shares both fall after Ozempic price-cut plan

Related Stories

China’s yuan strengthens to near 3-year high as US dollar uncertainty grows

Central Bank of Nigeria Reduces Interest Rate to 26.5%

January Inflation in Austria Drops to Two Percent

Germany's Deficit Rises Sharply

PERSPECTA